Accuray Q2 Earnings Call Highlights

Core Viewpoint - Accuray is undergoing a comprehensive transformation plan aimed at improving operational efficiency, accountability, and profitability, while facing challenges from geopolitical instability and tariff impacts, particularly in China. Financial Performance - Accuray reported a net revenue of $102.2 million for Q2, down 12% year-over-year, with product revenue falling to $45.0 million (down 26%) and service revenue increasing to $57.2 million (up 4%) [5][9][10] - The gross margin decreased to 23.5% from 36.1% a year ago, primarily due to a significant drop in product gross margin, which fell to 19.7% from 43.5% [5][12] - The company posted an operating loss of $11.6 million compared to an operating income of $4.7 million in the prior-year quarter, with adjusted EBITDA showing a loss of $1.9 million [13] Strategic Initiatives - The company is targeting an annualized operating profitability improvement of approximately $25 million, which includes a workforce reduction of about 15% and expects around $12 million of benefit in fiscal 2026 [2][5] - Accuray is focusing on expanding its service portfolio to create a "solutions-oriented" offering, enhancing uptime and driving higher-margin recurring revenue [7] - Initiatives include optimizing pricing, improving billing and collections, and building a structured distributor partnership program [6][7][8] Guidance and Outlook - The fiscal 2026 revenue guidance has been revised to $440 million to $450 million, with adjusted EBITDA expectations of $22 million to $25 million, reflecting ongoing volatility in China and tariff pressures [16][22] - Management aims for a high single-digit adjusted EBITDA margin run rate within nine months, with aspirations to reach double digits in the medium to long term [17] Market Dynamics - The decline in product revenue is attributed to geopolitical tensions and tariff impacts, particularly affecting the Chinese market [4][9][14] - Despite the challenges, discussions with customers indicate no significant downturn in hospital capital expenditure appetite [18] Balance Sheet - As of the end of the quarter, Accuray had $41.9 million in total cash and equivalents, down from $63.9 million in the previous quarter, primarily due to working capital usage and restructuring payments [19]